Aura Biosciences, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Aura Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2020 to Q3 2024.
  • Aura Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.75M, a 18.3% increase year-over-year.
  • Aura Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $11.4M, a 42.6% increase year-over-year.
  • Aura Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $8.77M, a 36.8% increase from 2022.
  • Aura Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.41M, a 178% increase from 2021.
  • Aura Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.31M, a 213% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $11.4M $2.75M +$425K +18.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $11M $3.13M +$1.2M +61.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $9.77M $2.91M +$996K +52.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $8.77M $2.6M +$784K +43.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $7.99M $2.33M +$613K +35.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $7.38M $1.93M +$644K +50% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $6.73M $1.91M +$319K +20% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $6.41M $1.82M +$522K +40.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $5.89M $1.71M +$1.16M +209% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $4.73M $1.29M +$1.02M +375% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $3.72M $1.59M +$1.41M +762% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $2.31M $1.3M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $554K +$363K +190% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $271K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $185K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $191K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.